Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2024
Total Assets: $13.06B
Liabilities Breakdown FY2024
Total Liabilities: $2.99B
Asset Breakdown
Total Assets: $13.06B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.05B | 23.3% |
| Accounts Receivable | $609.1M | 4.7% |
| Inventory | $1.09B | 8.3% |
| Property, Plant & Equipment | $1.69B | 12.9% |
| Goodwill | $1.78B | 13.6% |
| Intangible Assets | $1.18B | 9.0% |
| Other Assets | $3.68B | 28.1% |
Liabilities Breakdown
Total Liabilities: $2.99B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $197.4M | 6.6% |
| Long-Term Debt | $597.7M | 20.0% |
| Other Liabilities | $2.20B | 73.4% |